paw impress org growth
momentum continu
life scienc tool diagnost earn
ep exce consensu idxx ep handili beat
estimate higher revenu profit factor line ad
maintain organ revenu growth guidanc rais
ep guid midpoint rais ep
reflect fx dynam slightli higher expect
interest expens lower tax rate lower share base
monument chang underli growth forecast boost tp
ep higher view greater convict
sustain strength report revenu estimate
organ growth in-lin estimate in-lin estimate
driven us ou instrument sale in-lin includ
catalyst placement us consum slightli plan
estimate albeit reflect headwind fewer equival day bp meanwhil
ref lab rel line robust low-to-mid-teen growth us
hsd ou meanwhil rapid vs estimate disappoint vs
estimate lpd vs estimate well plan gross margin rose
bp mix/pric op expens rose bp bp less plan contribut
ebit margin contract bp bp plan flow million
help fund million share repurchas reserv stand million
share rise idxx share grind higher latest ep upsid
exceed meet expect across nearli everi categori focu sustain
organ top-line momentum guidanc call org growth also
remain encourag grow premium instal base catalyst placement
mostli new competit account well strength all-import organ
recur revenu repres total revenu guidanc
target recur growth continu view compel
altern hc invest durabl revenu consist price realiz
healthi fundament backdrop contribut greater predict visibl growth
valuat metric
number share
 close
legal entiti disclosur statu non-u analyst us disclosur credit suiss seek busi
compani cover research report result investor awar firm may conflict interest could
affect object report investor consid report singl factor make invest decis
profit tax
chang work capit
flow oper
free cash-flow firm
flow invest
chang net cash/debt
total liabil equiti
share wtd average
price book
roe stated-return
price
global leader diagnost point-of-car equip
refer laboratori servic companion anim also provid
system diagnost livestock water qualiti market
gain refer laboratori point-of-car acceler global
expans greater contribut innov new product launch
technolog advanc greater expect growth broader
expect macroeconom fx headwind increasingli
global footprint less adoption/tract futur product launch
 close
compani mention price
erin wilson wright certifi view express report accur reflect person view subject compani
secur part compens directli indirectli relat specif recommend view
express report
